|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 02-14-2005
NEW YORK (Reuters Health) - Women with breast cancer who take tamoxifen are less likely to have a heart attack than women with other types of cancer who are not taking the drug, according to a new report.
WASHINGTON (Reuters) - Shared moral values are less important than compatible personalities as a recipe for a good marriage, according to a study released on Sunday.
NEW YORK (Reuters) - Pfizer Inc. said on Monday that its Lyrica epilepsy drug reduced the frequency of partial seizures by as much as 53 percent when given as an add-on therapy to other antiepileptic treatments, according to a study in the journal Neurology.
NEW YORK (Reuters Health) - By transferring a gene that regulates fundamental cell development into the inner ear of deafened guinea pigs, researchers have regenerated so-called hair cells and partially restored the animals' hearing
NEW YORK (Reuters) - One day after the discovery of a drug-resistant, fast-developing AIDS case in New York prompted city health officials to announce an alert, leading experts said on Saturday there may be little cause for alarm.
NEW YORK (Reuters Health) - High blood pressure is a big risk factor for stroke, but people with normal blood pressure can have a stroke. In a new study, researchers have identified other key determinants of this debilitating neurologic problem.
SAN FRANCISCO (Reuters) - McDonald's has agreed to pay $8.5 million to settle a lawsuit over artery-clogging trans fats in its cooking oils, the company said on Friday.
LOS ANGELES (Reuters) - The head of the U.S. National Institutes of Health said he wants government and academic leaders to meet to address conflicts of interest in medical research, the Los Angeles Times reported on Saturday.
NEW YORK (Reuters Health) - Most people who live with serious disability or illness, such as kidney failure, appear to adapt well and maintain a healthy outlook on life, new research reports.
CHICAGO (Reuters) - Medical device maker Medtronic Inc. said on Friday it has begun warning doctors about some faulty batteries installed in a line of its implantable heart defibrillators.
|
|
